Inducing immune tolerance with dendritic cell-targeting nanomedicines

A Cifuentes-Rius, A Desai, D Yuen… - Nature …, 2021 - nature.com
Induced tolerogenic dendritic cells are a powerful immunotherapy for autoimmune disease
that have shown promise in laboratory models of disease and early clinical trials. In contrast …

Targeting dendritic cells to advance cross-presentation and vaccination outcomes

C Macri, D Jenika, C Ouslinis, JD Mintern - Seminars in immunology, 2023 - Elsevier
Dendritic cells (DCs) are a complex network of specialised antigen-presenting cells that are
critical initiators of adaptive immunity. Targeting antigen directly to DCs in situ is a …

Cell‐specific targeting of extracellular vesicles through engineering the glycocalyx

W Zheng, R He, X Liang, S Roudi, J Bost… - Journal of …, 2022 - Wiley Online Library
Extracellular vesicles (EVs) are promising carriers for the delivery of a variety of chemical
and biological drugs. However, their efficacy is limited by the lack of cellular specificity …

Biomaterials to enhance antigen-specific T cell expansion for cancer immunotherapy

A Isser, NK Livingston, JP Schneck - Biomaterials, 2021 - Elsevier
T cells are often referred to as the 'guided missiles' of our immune system because of their
capacity to traffic to and accumulate at sites of infection or disease, destroy infected or …

Selective tumor antigen vaccine delivery to human CD169+ antigen-presenting cells using ganglioside-liposomes

AJ Affandi, J Grabowska, K Olesek… - Proceedings of the …, 2020 - National Acad Sciences
Priming of CD8+ T cells by dendritic cells (DCs) is crucial for the generation of effective
antitumor immune responses. Here, we describe a liposomal vaccine carrier that delivers …

Innovative immunization strategies for antivenom development

E Bermúdez-Méndez, A Fuglsang-Madsen, S Føns… - Toxins, 2018 - mdpi.com
Snakes, scorpions, and spiders are venomous animals that pose a threat to human health,
and severe envenomings from the bites or stings of these animals must be treated with …

Donor macrophages modulate rejection after heart transplantation

BJ Kopecky, H Dun, JM Amrute, CY Lin… - Circulation, 2022 - Am Heart Assoc
Background: Cellular rejection after heart transplantation imparts significant morbidity and
mortality. Current immunosuppressive strategies are imperfect, target recipient T cells, and …

[HTML][HTML] Glyco-dendrimers as intradermal anti-tumor vaccine targeting multiple skin DC subsets

S Duinkerken, SK Horrevorts, H Kalay, M Ambrosini… - Theranostics, 2019 - ncbi.nlm.nih.gov
The human skin is an attractive anti-tumor vaccination site due to the vast network of
dendritic cell (DC) subsets that carry antigens to the draining lymph nodes and stimulate …

TNFα and IFNγ cooperate for efficient pro-to anti-inflammatory transition of macrophages during muscle regeneration

F Babaeijandaghi, A Paiero, R Long… - Proceedings of the …, 2022 - National Acad Sciences
IFNγ is traditionally known as a proinflammatory cytokine with diverse roles in antimicrobial
and antitumor immunity. Yet, findings regarding its sources and functions during the …

Carbohydrate-lectin interactions reprogram dendritic cells to promote type 1 anti-tumor immunity

V Lensch, A Gabba, R Hincapie, SH Bhagchandani… - ACS …, 2024 - ACS Publications
Cancer vaccine development is inhibited by a lack of strategies for directing dendritic cell
(DC) induction of effective tumor-specific cellular immunity. Pathogen engagement of DC …